FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387213464> ?p ?o ?g. }

• W4387213464 endingPage "117312" @default.
• W4387213464 startingPage "117312" @default.
• W4387213464 abstract "Dyslipidemia refers to unhealthy changes in blood lipid composition and is a risk factor for atherosclerotic cardiovascular diseases (ASCVD). Usually, low-density lipoprotein-cholesterol (LDL-C) is the primary goal for dyslipidemia management. However, non-high-density lipoprotein cholesterol (non-HDL-C) has gained attention as an alternative, reliable goal. It encompasses all plasma lipoproteins like LDL, triglyceride-rich lipoproteins (TRL), TRL-remnants, and lipoprotein a [Lp(a)] except high-density lipoproteins (HDL). In addition to LDL-C, several other constituents of non-HDL-C have been reported to be atherogenic, aiding the pathophysiology of atherosclerosis. They are acknowledged as contributors to residual ASCVD risk that exists in patients on statin therapy with controlled LDL-C levels. Therefore, non-HDL-C is now considered an independent risk factor or predictor for CVD. The popularity of non-HDL-C is attributed to its ease of estimation and non-dependency on fasting status. It is also better at predicting ASCVD risk in patients on statin therapy, and/or in those with obesity, diabetes, and metabolic disorders. In addition, large follow-up studies have reported that individuals with higher baseline non-HDL-C at a younger age (<45 years) were more prone to adverse CVD events at an older age, suggesting a predictive ability of non-HDL-C over the long term. Consequently, non-HDL-C is recommended as a secondary goal for dyslipidemia management by most international guidelines. Intriguingly, geographical patterns in recent epidemiological studies showed remarkably high non-HDL-C attributable mortality in high-risk countries. This review highlights the independent role of non-HDL-C in ASCVD pathogenesis and prognosis. In addition, the need for a country-specific approach to dyslipidemia management at the community/population level is discussed. Overall, non-HDL-C can become a co-primary or primary goal in dyslipidemia management." @default.
• W4387213464 created "2023-10-01" @default.
• W4387213464 creator A5007862850 @default.
• W4387213464 creator A5022085199 @default.
• W4387213464 creator A5023972061 @default.
• W4387213464 creator A5035168358 @default.
• W4387213464 creator A5037200495 @default.
• W4387213464 creator A5045569702 @default.
• W4387213464 creator A5048145643 @default.
• W4387213464 creator A5049639208 @default.
• W4387213464 creator A5068395011 @default.
• W4387213464 creator A5076756862 @default.
• W4387213464 creator A5076770998 @default.
• W4387213464 creator A5083608505 @default.
• W4387213464 creator A5092973770 @default.
• W4387213464 date "2023-10-01" @default.
• W4387213464 modified "2023-10-14" @default.
• W4387213464 title "Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook" @default.
• W4387213464 cites W1725677343 @default.
• W4387213464 cites W1949072443 @default.
• W4387213464 cites W1964186620 @default.
• W4387213464 cites W1975018096 @default.
• W4387213464 cites W1995165377 @default.
• W4387213464 cites W2030551858 @default.
• W4387213464 cites W2032275737 @default.
• W4387213464 cites W2057271480 @default.
• W4387213464 cites W2079102359 @default.
• W4387213464 cites W2089639307 @default.
• W4387213464 cites W2130132335 @default.
• W4387213464 cites W2132196134 @default.
• W4387213464 cites W2134306662 @default.
• W4387213464 cites W2154836846 @default.
• W4387213464 cites W2164962892 @default.
• W4387213464 cites W2195921894 @default.
• W4387213464 cites W2261535787 @default.
• W4387213464 cites W2277974059 @default.
• W4387213464 cites W2286999219 @default.
• W4387213464 cites W2328529137 @default.
• W4387213464 cites W2341665659 @default.
• W4387213464 cites W2418398572 @default.
• W4387213464 cites W2548291596 @default.
• W4387213464 cites W2563462192 @default.
• W4387213464 cites W2588374583 @default.
• W4387213464 cites W2734525258 @default.
• W4387213464 cites W2772281339 @default.
• W4387213464 cites W2914610649 @default.
• W4387213464 cites W2921999427 @default.
• W4387213464 cites W2942254260 @default.
• W4387213464 cites W2948745207 @default.
• W4387213464 cites W2949181149 @default.
• W4387213464 cites W2991680466 @default.
• W4387213464 cites W2996456596 @default.
• W4387213464 cites W3006116566 @default.
• W4387213464 cites W3011963422 @default.
• W4387213464 cites W3016388449 @default.
• W4387213464 cites W3033499384 @default.
• W4387213464 cites W3036336535 @default.
• W4387213464 cites W3049758098 @default.
• W4387213464 cites W3107432659 @default.
• W4387213464 cites W3121485057 @default.
• W4387213464 cites W3129818723 @default.
• W4387213464 cites W3139070968 @default.
• W4387213464 cites W3139103423 @default.
• W4387213464 cites W3159298722 @default.
• W4387213464 cites W3183857127 @default.
• W4387213464 cites W3185962386 @default.
• W4387213464 cites W3189022515 @default.
• W4387213464 cites W3197233987 @default.
• W4387213464 cites W3197326839 @default.
• W4387213464 cites W3211755826 @default.
• W4387213464 cites W3213895219 @default.
• W4387213464 cites W4200475605 @default.
• W4387213464 cites W4210282381 @default.
• W4387213464 cites W4220799853 @default.
• W4387213464 cites W4224317165 @default.
• W4387213464 cites W4237223373 @default.
• W4387213464 cites W4238251256 @default.
• W4387213464 cites W4293490519 @default.
• W4387213464 cites W4308367139 @default.
• W4387213464 cites W4310055568 @default.
• W4387213464 cites W4312216351 @default.
• W4387213464 cites W4317107928 @default.
• W4387213464 cites W4327595719 @default.
• W4387213464 cites W4385401865 @default.
• W4387213464 doi "https://doi.org/10.1016/j.atherosclerosis.2023.117312" @default.
• W4387213464 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37826864" @default.
• W4387213464 hasPublicationYear "2023" @default.
• W4387213464 type Work @default.
• W4387213464 citedByCount "0" @default.
• W4387213464 crossrefType "journal-article" @default.
• W4387213464 hasAuthorship W4387213464A5007862850 @default.
• W4387213464 hasAuthorship W4387213464A5022085199 @default.
• W4387213464 hasAuthorship W4387213464A5023972061 @default.
• W4387213464 hasAuthorship W4387213464A5035168358 @default.
• W4387213464 hasAuthorship W4387213464A5037200495 @default.
• W4387213464 hasAuthorship W4387213464A5045569702 @default.
• W4387213464 hasAuthorship W4387213464A5048145643 @default.
• W4387213464 hasAuthorship W4387213464A5049639208 @default.

• next